Eastern Bank’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
LMFP
CIM
CGH
CNB
AP
COPPSERS
Eastern Bank's GILD Position: Q2 2026 in Review
Eastern Bank increased its Gilead Sciences (GILD) stake by 17% in Q2 2026, buying an estimated $52.2K and bringing the position to 2,710 shares worth $342K. The position accounts for 0.01% of the portfolio, ranked #328.
Eastern Bank first reported a position in GILD in Q3 2024 and has held it in 8 quarters since. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Eastern Bank held 2,710 shares of Gilead Sciences worth $342K as of Q2 2026.
- Eastern Bank bought 396 Gilead Sciences shares in Q2 2026, an estimated $52.2K.
- Gilead Sciences made up 0.01% of Eastern Bank's portfolio in Q2 2026, its #328 holding.
- Eastern Bank first reported a position in Gilead Sciences in Q3 2024 and has held it in 8 quarters since.
- 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.